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Abstract 
 
αį-Bungarotoxins, a novel group of long-chain α-neurotoxins, manifest different affinity 
to two agonist/competitive antagonist binding sites of muscle-type nicotinic acetylcholine 
receptors, being more active at the interface of α-į-subunits. Three isoforms (αį-BgTx-1-3) were 
identified in Malayan Krait (Bungarus candidus) from Thailand by genomic DNA analysis; two 
of them (αį-BgTx-1 and 2) were isolated from its venom. The toxins comprise 73 amino acid 
residues and 5 disulfide bridges, being homologous to α-bungarotoxin (α-BgTx), a classical 
blocker of muscle-type and neuronal α7, α8, and α9α10 nicotinic acetylcholine receptors. The 
toxicity of αį-BgTx-1 (LD50 0.17–0.28 μg/g mouse, i.p. injection) is essentially as high as that 
of α-BgTx. In the chick biventer cervicis nerve-muscle preparation, αį-BgTx-1 completely 
abolished acetylcholine response, but in contrast to the block by α-BgTx, acetylcholine response 
was fully reversible by washing. αį-BgTxs, similar to α-BgTx, bind with high affinity to α7 and 
muscle-type nicotinic acetylcholine receptors. However, the major difference of αį-BgTxs from 
α-BgTx and other naturally-occurring α-neurotoxins is that αį-BgTxs discriminate the two 
binding sites in the Torpedo californica and mouse muscle nicotinic acetylcholine receptors 
showing up to two orders of magnitude higher affinity for the α-į site as compared to α-İ or α-Ȗ 
binding site interfaces. Molecular modeling and analysis of the literature provided possible 
explanations for these differences in binding mode; one of the probable reasons being the lower 
content of positively charged residues in αį-BgTxs. Thus, αį-BgTxs are new tools for studies on 
nicotinic acetylcholine receptors. 
 
Abbreviations list: AChBP, acetylcholine binding protein; BSA, bovine serum albumin; α-
BgTx, α-bungarotoxin; αį-BgTx, αį-bungarotoxins; α-CTX, α-cobratoxin; hα7, human α7; 
nAChR, nicotinic acetylcholine receptor 
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Introduction 
 
Nicotinic acetylcholine receptors (nAChRs) belong to the large family of ligand-gated ion 
channels and consist of five identical or homologous polypeptide subunits arranged with radial 
symmetry around a central pore [1-3]. In the muscle type nAChR, two copies of α1 and one each 
of the ȕ1, į, and Ȗ subunits (in the embryonic receptor form) or İ subunit (in the adult form) are 
arranged around that pore in counter-clockwise order α1-Ȗ/İ-α1-į-ȕ1 [4-5]. The binding sites for 
agonists and competitive antagonists are located at the interfaces of the α1-į and α1-Ȗ (or α1-İ) 
subunits [6]. Full activation of the nAChR requires the simultaneous binding of two agonist 
molecules, but antagonists can block activation by occupying only one of the two sites [7]. The 
neuronal α7 type nAChR is composed of five identical α7 subunits and possesses a spatial 
organization similar to that of the muscle-type receptor [8]. 
 
The venoms of snakes of the Elapidae family are rich sources of toxins targeting nicotinic 
acetylcholine receptors. Structurally, two groups of these toxins are distinguished: "short α-
neurotoxins" consisting of 60 - 62 amino acid residues in a single chain that is cross-linked 
intramolecularly by four disulfide bonds, and "long α-neurotoxins" consisting of 66 - 74 amino 
acid residues and five disulfide bonds [9]. Collectively, short and long neurotoxins form a part of 
the "three-fingered" group of snake toxins [10-11]. Their members exhibit a characteristic three-
loop topology in which each of the three fingers extends from a core "knuckle" region consisting 
of four conserved disulfide bonds. Other snake toxins sharing this three-fingered structure 
include so-called non-conventional or weak toxins [12-13], some of them acting on nAChRs, and 
functionally quite divergent molecules like cyto-/cardio-toxins, fasciculins (an inhibitor of 
acetylcholinesterase), toxins blocking muscarinic receptors or calcium channels (calciseptine), 
and several others whose targets still await identification. 
 
Short and long snake α-neurotoxins like α-bungarotoxin (α-BgTx) [14, 15] from the 
venom of the Many-banded Krait (Bungarus multicinctus) have been used to probe nAChRs for 
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over 40 years [16]. They continue to be valuable tools in studies of the nAChR structure, 
function and levels at normal state and in various pathologies (e.g., [10-11, 17]). In recent years, 
they have been joined by shorter peptides like α-conotoxins [18-20] from cone snail (Conus spp.) 
venoms, waglerins [21] from the venom of the Temple Viper (Tropidolaemus wagleri) and 
azemiopsin of Fea’s Viper (Azemiops feae) [22] which in contrast to α-BgTx and other 
frequently used elapid snake neurotoxins were found to discriminate between receptor subtypes, 
the two binding sites of muscle nAChRs, and the receptors of various animal species [23-25]. 
 
Here we report novel snake long-chain neurotoxins, αį-bungarotoxins (αį-BgTxs), which 
have different affinities for the two binding sites of the muscle-type nAChRs, induce reversible 
block of the nAChR, bind also to the neuronal α7 nAChR, and combine these properties with 
high toxicity and great structural similarity to the classic receptor probe α-BgTx. The name αį-
bungarotoxins has been selected to highlight this structural similarity as well as their preferential 
binding at the nAChR α-į subunit interface. 
 
Materials and Methods 
 
Isolation of αį-BgTxs 
 
Three different batches of Bungarus candidus venom were used in this study: one from 
snakes from Surat Thani, southern Thailand, kept at the Faculty of Tropical Medicine of Mahidol 
University, Bangkok (sample A), and two (samples B and C) from southern Thailand snakes kept 
at the Queen Saovabha Memorial Institute (QSMI), Bangkok. After milking, venom was 
lyophilized immediately. The separation procedures included gel-filtration, ion-exchange and 
reversed phase chromatography either essentially as described in [26], or by using a Superdex 75 
column (10 × 300 mm, GE Healthcare) for gel-filtration, HEMA BIO 1000CM column (8 × 250 
mm, Tessek, Prague, Czech Republic) for ion-exchange chromatography and a Jupiter C18 
column (10 × 250 mm, Phenomenex, Torrance, CA, USA) for reversed phase HPLC. Crude B. 
candidus venom (65 mg) was dissolved in 0.65 ml of 0.1 M ammonium acetate buffer (pH 6.2) 
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and separated on the Superdex 75 column equilibrated with the same buffer at a flow rate of 30 
ml/h. The eluting proteins were detected by absorbance at 280 nm. The fractions were pooled 
(Fig. 1A) and analyzed by mass-spectrometry. Fraction 8 (Fig. 1A), containing toxins with a 
molecular mass of 8031 and 8143.5 Da, was further separated on the HEMA BIO 1000 CM 
column using a gradient of 5 to 45 mM ammonium acetate in 100 min at a flow rate of 1.0 
ml/min. Fractions obtained (Fig. 1B) were analyzed by mass-spectrometry and separated further 
on the Phenomenex C18 column applying a gradient of 20% to 40 % acetonitrile (v/v, in 60 min) 
containing 0.1% (v/v) trifluoroacetic acid (TFA), at a flow rate of 2.0 ml/min (Supplementary 
Figure 1). Purification prior to amino acid sequencing procedures was achieved by RP-HPLC on 
 
a BDS-Hypersil-C18 column (125 × 4 mm; Hewlett-Packard, Palo Alto, CA, USA) equilibrated 
with 0.1% TFA in water, using a linear gradient of 0–80% acetonitrile in 0.1% TFA at a flow 
rate of 0.5 ml/min over 45 min. Absorbance was monitored at 220 nm. 
 
Molecular mass determination 
 
Venom fractions and isolated toxins were analyzed by HPLC-MS using a Thermo 
Finnigan LCQ Deca XP mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA) and 
a Thermo Accela UPLC system (Thermo Fisher Scientific, Waltham, MA, USA). Detection was 
performed using UV-VIS DAD and MS (ESI+, 150–2000 units). Peptide mass fingerprinting 
was performed using Ultraflex III MALDI-TOF/TOF (Bruker Daltonics, Billerica, MA, USA). 
 
Amino acid sequence determination 
 
N-terminal sequence analysis of intact and proteolytically digested toxin samples from 
venom sample A were performed using a Procise HT sequencer instrument (Applied Biosystems, 
Foster City, CA, USA) with S-carboxymethylated samples immobilized on PVDF membranes. 
Carboxymethylation and digestion with Asp-N and Glu-C proteases were performed as described 
 
[26]. Digested samples were separated by RP-HPLC using a Vydac C8 column at 0.2 ml/min and 
detection at 214 nm. N-terminal sequence analysis of the native toxin from venom sample B was 
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carried out as described [26]. The amino acid sequence of αį-BgTx-1 has been deposited in the 
 
UniProtKB database (primary accession number: A1IVR8). 
 
Cloning and sequence analysis of genomic DNAs encoding αį-BgTx isoforms 
 
Total DNA was isolated from shed skin material of one of the B. candidus from southern 
Thailand that had been used for venom extraction. PCR, cloning and DNA sequencing were 
performed as described in [26] using the amplification primers P2 [27], which is based on the 3´-
non-coding region of the cobrotoxin and cardiotoxin genes [28], and P5 (Supplementary Table 
1), which corresponds to a sequence just upstream of a tandem repeat which in turn is upstream 
from exon 2 of the α-BgTx (A31) gene [27] (Supplementary Figure 2). The sequences were 
aligned against the published nucleotide sequences of the α-BgTx (A31) gene and cDNA 
(accession nos. Y17694 and Y17058, respectively [27]). Sequence similarity was assessed using 
BLASTN 2.2.8 [29] by comparing the new genomic and their combined coding sequences to the 
database. Theoretical masses and theoretical isoelectric points (pIs) of polypeptides were 
calculated using the ExPASy Compute pI/Mw Tool [30]. The nucleotide sequences of the partial 
genes of the three αį-BgTx isoforms from Thai B. candidus have been deposited in the 
DDBJ/EMBL/GenBank Nucleotide Sequence Database under the accession numbers AM231681 
(partial αį-Bgt-1 gene for αį-BgTx-1), Aεβγ168β (partial αį-Bgt-β gene for αį-BgTx-2), and 
AM231680 (partial αį-Bgt-γ gene for αį-BgTx-3). 
 
Toxicity assays 
 
Lethal toxicity was assayed as described [26] in Swiss mice of both sexes weighing 18– 
20 g. LD50 and its confidence limits at 95% probability were calculated by the methods of Reed-
Muench [31] and Pizzi [32], respectively. Animal experiments were performed at Queen 
Saovabha Memorial Institute after approval and under the supervision of the Queen Saovabha 
Memorial Institute Animal Care and Use Committee (QSMI-ACUC). The experimental 
procedure was reviewed and approved by the Committee in accordance with Queen Saovabha 
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Memorial Institute regulations and policies governing the care and use of laboratory animals. 
The review followed guidelines documented in the “Ethical Principles and Guidelines for the 
Use of Animals for Scientific Purposes” edited by the National Research Council of Thailand. 
 
Chick biventer cervicis nerve-muscle assay 
 
The neuromuscular blocking activity of αį-BgTx-1 was compared to that of α-BgTx 
(A31) as described [33] using the isolated biventer cervicis nerve-muscle preparation from 4–7-
day-old chicks. The response of the muscle to acetylcholine (100 μM) was recorded for 60 sec 
before and after treatment with the toxin fractions. During the test of acetylcholine response, the 
electrical stimulation was suspended. 
 
Synthesis of radioiodinated αį-BgTx-1 and α-BgTx 
 
The synthesis of radioactive α-BgTx was carried out essentially as described [34]. For 
this study, a product with a specific radioactivity of 500 curies/mmol was obtained. α-BgTx (400 
pmoles) dissolved in 20 μL of 125 mM sodium phosphate buffer, рН 7.5, was incubated for 10 
min at room temperature with a mixture of 100 pmoles of Na[125I] and 300 pmoles of NaI and 4 
nmoles of chloramine T. The reaction products were separated by ion-exchange HPLC in a 5 
mM sodium-phosphate buffer, pH 7.5, using a gradient of 0.2 M NaCl (2–62% for 30 min) on a 
TSKgel CM-5PW column (75 × 7.5 mm) at a flow rate of 0.5 mL/min. Detection was carried out 
at 226 nm and the iodinated products were collected in 0.5 min fractions. Aliquots of all fractions 
were counted on a Wizard 1470 Automatic Gamma Counter (Perkin Elmer, Shelton, CT, USA). 
The mono-iodinated [125I]α-BgTx derivative (with approximate specific radioactivity of 500 
Ci/mmol) was collected and kept not longer than 1 month at 4 °C in a 50 mM Tris-НС1 buffer, 
рН 7.5, containing 0.1 mg/ml BSA. 
 
Radio-iodinated αį-BgTx-1 was prepared according to the same protocol as above, but 
using 280 pmoles of the toxin, 70 pmoles of Na[125I], 210 pmoles of NaI and 2.8 nmoles of 
chloramine T, and applying a different gradient (5–60% for 60 min) with the same column and 
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solutions to separate the iodination products. Mono-iodinated [125I]αį-BgTx-1 and α-BgTx 
derivatives were used in parallel experiments of radioligand assays on muscle-type nAChR from 
the electric organ of the Torpedo californica ray and human α7 (hα7) nAChR expressed in 
GH4C1 cells. 
 
Receptor binding assays 
 
Four types of nAChR were examined: the adult (α1ȕ1įİ) and embryonic form (α1ȕ1įȖ) 
mouse muscle nAChRs, the α1ȕ1Ȗį muscle-type nAChR from the electric organ of T. 
californica, and the neuronal hα7 nAChR expressed in the GH4C1 cell line. For competition 
binding assays using mouse muscle nAChRs, cloned cDNAs for mouse α1, ȕ1, į, and İ or Ȗ 
nAChR subunits were sub-cloned into the CMV promotor-based mammalian expression vector 
pRBG4 [35] at EcoRI sites. The individual subunit cDNAs of the nAChR are present on separate 
plasmids. HEK293 cells were transfected using the calcium phosphate precipitation method [36]. 
The medium was changed 12–16 h later and the experiments were performed 1-2 days after the 
medium change. GH4C1 cells transfected with hα7 nAChR cDNA were a gift of the Eli-Lilly 
Co. (London, UK). Muscle-type nAChR-enriched membranes from the electric organs of T. 
californica were kindly provided by Prof. F. Hucho (Free University of Berlin, Germany). The 
binding assays on mouse muscle nAChRs were performed using αį-BgTxs, a commercial 
sample of unlabeled α-BgTx (Sigma-Aldrich, St. Louis, MO, USA), α-BgTx (A31) isolated from 
Javan B. candidus venom [26], [125I]α-BgTx (New England Nuclear, Boston, MA, USA), or α-
conotoxin MI (American Peptide Co., Sunnyvale, CA, USA) which had been radioiodinated as 
described [37]. The binding assays on neuronal hα7 and T. californica nAChRs were performed 
using αį-BgTxs, and with α-BgTx (A31) isolated from Vietnamese B. multicinctus venom 
obtained as described [38]. 
 
Estimation of αį-BgTx-1 binding to mouse muscle nAChRs 
 
 
 
 
 
8 
To dissociate the transfected cells from plates, the culture medium was removed, and the 
cells were gently agitated with 5 ml PBS (pH 7.4) containing 5 mM EDTA. The dissociated cell 
suspension was centrifuged at 1000 g for 1 min and re-suspended to a final concentration of 40-
100 pM α-BgTx binding sites in high K+ Ringer's buffer (140 mM KCl, 5.4 mM NaCl, 1.8 mM 
CaCl2, 1.2 mM MgCl2, 25 mM HEPES, and 30 mg/l bovine serum albumin [BSA]). Aliquots of 
intact dissociated cells were incubated overnight with the test toxin at room temperature to 
ensure equilibrium was reached between toxin and receptor. [125I]α-BgTx was added to a final 
concentration of 5 nM and allowed to incubate 30 min with the receptor until 30–50% of the 
available binding sites were occupied [36, 37, 39]. The fraction of the nAChR binding sites 
occupied by αį-BgTx-1 was determined by calculating the reduction of the initial association 
rate of [125I]α-BgTx observed in the presence of each concentration of competing toxin (konobs) 
compared to the maximum association rate in the absence of the competing ligand (konmax). The 
total number of sites was determined by incubation with 20 nM [125I]α-BgTx for 1 h. 
Nonspecific binding was determined by incubating the cells with 10 mM carbachol or 10 M 
 
unlabeled α-BgTx before adding [125I]α-BgTx; comparable values of non-specific binding were 
obtained for both carbachol and α-BgTx. In a separate series of assays, 30 nM α-conotoxin MI 
was added to the assay mixture after incubation with αį-BgTx-1 and before adding [125I]α-
BgTx. This concentration of α-conotoxin MI will occupy ~98% of the available αį subunit 
interface sites and <10% and <1% of the αİ and αȖ interface bindings sites, respectively [37]. 
Transformed data were fit to the one site or two site Hill equation using Prism 3.0 (Graphpad). 
 
Estimation of αį-BgTx binding to Torpedo californica muscle-type and human neuronal α7 
 
nAChRs 
 
For competition binding assays, suspensions of nAChR-rich membranes from T. 
californica electric organ (1.25 nM α-bungarotoxin binding sites) in 20 mM Tris-HCl buffer pH 
8.0 containing 1 mg/ml BSA (binding buffer) or hα7 nAChR transfected GH4C1 cells (0.9 nM α- 
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bungarotoxin binding sites) in binding buffer were incubated for 1.5 h at room temperature with 
various amounts of the different αį-BgTxs, followed by an additional 30 min incubation with 1 
nM [125I]α-BgTx. Nonspecific binding was determined by preliminary incubation of the 
preparations with 20 µM α-cobratoxin. The membrane and cell suspensions were applied to glass 
GF/C filters (Whatman, Maidstone, UK) presoaked in 0.25% polyethylenimine, and unbound 
radioactivity was removed from the filter by washing (3 × 3 ml) with 20 mM Tris-HCl buffer, 
pH 8.0, containing 0.1 mg/ml BSA (washing buffer). The bound radioactivity was determined 
using a Wizard 1470 Automatic Gamma Counter. The binding results were analyzed using 
ORIGIN 7.5 (OriginLab Corporation, Northampton, MA, USA) fitting to one site or two site 
dose-response competition curves. 
 
The equilibrium saturation binding of the [125I]αį-BgTx-1 with the T. californica nAChR 
(1.25 nM α-bungarotoxin binding sites) or hα7 nAChR in GH4C1 cells (0.9 nM α-bungarotoxin 
binding sites) was carried out in 50 μL of binding buffer at room temperature. Various 
concentrations of the radioligand (0.02–1.25 nM) were incubated with the targets for 1 hr. Non-
specific binding was determined in the presence of 10 μM of α-cobratoxin (1 h pre-incubation). 
The filtration on GF/C filters was performed as mentioned above. The equilibrium binding data 
were fitted using ORIGIN 7.5 to a one site model according to the Equation: B(x) = Bmax/(1 + 
Kd/x), where B(x) is the radioligand specifically bound at free concentration x (determined by 
subtracting the amount of bound and adsorbed radioligand from the total amount added to the 
incubation mixture), Bmax is the maximal specific bound radioligand, and Kd is the dissociation 
constant. 
Estimation of dissociation kinetics by radioligand analysis 
 
To evaluate the dissociation kinetics of [125I]αį-BgTx-1 and [125I]α-BgTx from the 
complex with the T. californica nAChR or hα7 nAChR, binding of the 0.3 nM radioligands was 
allowed to reach equilibrium (1.5 h incubation) in binding buffer at room temperature, after 
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which a saturating concentration of α-cobratoxin (10 μM) was added to prevent any re-
association of the radioligands to the receptors. The reactions were terminated by rapid filtration 
on the GF/C filters as mentioned above for different time intervals (2 to 120 min). To calculate 
koff values, the experimental data were fitted to an exponential equation: 
Bp = 100 × (− × ), where Bp is the percentage of the binding complex, t is time (min). 
 
 
In the case of [125I]αį-BgTx-1 dissociation from the T. californica nAChR the best fit was achieved with a biexponential equation: Bp = a1 × (− 1 × ) + a2 × (− 2 × ), 
 
 
where a1 + a2 = 100%. 
 
Electrophysiological assays on Xenopus oocytes 
 
Electrophysiological assays on Xenopus laevis oocytes were performed as described [40]. 
Various concentrations of αį-BgTx-1 were first applied to an oocyte for 5 min, followed by 
adding the agonist ACh (30 µM, which is equal to the EC100 on muscle type nAChR and the 
 
EC10 on γȕβ nAChR). To test the reversibility of the nAChR block produced by αį-BgTx-1, 
the receptor was incubated with 0.112 mg/ml αį-BgTx-1 for 10 min. Then the oocytes were 
washed with bath buffer (0.4 ml/min) and the response to 30 µM ACh was measured every 5 
min. 
 
Molecular modeling of αį-BgTx-1 and docking simulations 
 
The structure of α-BgTx was taken from the crystal structure of its complex with the 
extracellular domain of the nAChR α1 subunit [41]. A model of the structure of αį-BgTx-1 was 
built with the Modeller 8v1 package [42] using the α-BgTx structures as a template. The model 
of the acetylcholine binding protein (AChBP) of Lymnaea stagnalis was taken from the α-
cobratoxin-AChBP crystal structure ([43]; PDB 1YI5). Extracellular domains of the α and Ȗ 
subunits of the T. californica nAChR were built with the Modeller 8v1 package using the 
structure of the T. marmorata nAChR ([44]; PDB 2BG9) as a template. The position of the C- 
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loop in the nAChR model was adopted from the α-cobratoxin-AChBP crystal structure [43]. 
 
Docking simulations were performed using the programme HEX 4.5 
(http://www.csd.abdn.ac.uk/hex/) [45]. 
 
Results 
 
Isolation of αį-BgTxs 
 
Three different batches of B. candidus venom from southern Thailand were used in this 
study for the isolation of αį-BgTxs. In one purification scheme, the crude venom was separated 
first by gel-filtration on a Superdex 75 column (Fig. 1A). Twelve fractions were collected and 
analyzed by mass-spectrometry. Fraction 8, containing toxins with molecular masses of 8031 and 
8143.5 Da, was further separated by ion exchange chromatography (Fig. 1B). Likewise, the 
seven fractions obtained were analyzed by mass-spectrometry. The MS-spectra of fractions 3 and 
4 were identical showing one major peak corresponding to a molecular mass of 8143.5 Da. MS-
spectra of fractions 6 and 7 were also identical exhibiting a molecular mass of 8031 Da. The 
fractions 3, 4, 6 and 7 were further purified by reversed phase HPLC (Supplementary Figure 1) 
and were used for further studies. Fractions 3 and 4 showed very similar profiles with one 
predominant peak of a molecular mass of 8143.5 Da. One main peak was seen in the profiles of 
fractions 6 and 7 with a molecular mass of 8031 Da. Peptide mass fingerprinting confirmed the 
identity of proteins in fraction 3 and 4 as well as in fractions 6 and 7, respectively. 
 
To obtain more material for the study, two other batches of crude venom were 
fractionated essentially as described [26] using gel-filtration on Sephadex G-75, ion-exchange 
chromatography on SP-Sephadex C-25 and Resource S columns, and finally by RP-HPLC on a 
BDS-Hypersil-C18 column. 
 
Genomic DNA sequence analysis 
 
PCR amplification using genomic DNA from B. candidus and the primers P2 and P5 
provided PCR fragments which migrated as a single band in agarose gel electrophoresis and 
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were estimated to be ~1 kb. The DNA fragments were subcloned and clones were selected for 
nucleotide sequencing of both strands. Three unique genomic DNAs of 910, 930 and 934 bp 
were unequivocally constructed from the nucleotide sequences. They were composed of 
sequences that correspond to the complete toxin-coding regions of the two previously reported 
genomic DNAs for α-BgTx A31 and V31, which consist of 2924 and 2925 bp [27]. Alignment of 
the cDNA sequence and the gene for α-BgTx (A31) with the genomic DNAs obtained from B. 
candidus allowed the assignment of intron/exon boundaries, which are virtually identical to those 
of the α-BgTx (A31) genes of B. multicinctus from Taiwan [27] and B. candidus from Java [26]. 
They confirm the common gene organization of elapid snake cardiotoxins, short neurotoxins, and 
long neurotoxins, i.e., three exons separated by two introns inserted into similar positions in the 
coding regions [27, 28, 46-48; Supplementary Figure 2]. Compared to α-BgTx (A31) [26, 27], 
the three αį-BgTx encoding genomic DNAs from Thai B. candidus include a much larger partial 
intron 1 region (138 bp) that has a 102 bp insertion with high (97%) similarity to an upstream 
intron 1 sequence from the α-BgTx A31 gene of Taiwanese B. multicinctus but lacks a tandem 
repeat that is inserted in close proximity of the 3'-splice acceptor site of the α-BgTx genes 
(positions 1886 to 2089 in the A31 variant [27]). They also lack an (AT)9 dinucleotide repeat 
upstream from the 3'-splice acceptor site, which is present in the α-BgTx A31 genes of both B. 
multicinctus from Taiwan and B. candidus from Java. Both exon 2 (with a one-codon deletion) 
and intron 2 (consisting of 534 vs. 537–539 bp) of the three αį-BgTx encoding genomic DNAs 
are shorter than those of the α-BgTx A31 genes. The 5'-splice donor sequence of exon 2 of the 
αį-BgTx DNAs (ATGGT) also differs from that of the α-BgTx A31 and V31 genes (ATTCT) 
[26, 27]. The first exon of the three partial αį-BgTx genes encodes a part of the signal peptide of 
α-BgTx (Gly, Tyr, Thr) and the 31 N-terminal amino acids of the mature toxins (32 in α-BgTx; 
Fig. 2). Their second exon region is highly similar to that of exon 3 of the α-BgTx genes and 
encodes the 42 C-terminal amino acids of the mature toxins and a short 
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fragment of the subsequent 3'-non-coding region. The three αį-BgTx DNAs encode the mature 
αį-BgTx polypeptide sequence as determined by amino acid sequencing (αį-BgTx-1) and two 
additional isoforms (αį-BgTx-2 and αį-BgTx-3) that differ from αį-BgTx-1 in having Val40 
(like α-BgTx) and Asp74 instead of Gly74 as in αį-BgTx-1 and α-BgTx. Ile9 and Ile31 in αį-
BgTx-2 differentiate it from αį-BgTx-1, αį-BgTx-3 and α-BgTx (Fig. 2; Supplementary Figures 
3 and 4). 
 
Mass spectrometry analysis and amino acid sequences 
 
The toxins in fraction 3, 4, 6 and 7 were subjected to ESI-MS analysis (Fig. 3). The MS-
spectra of the proteins in fraction 6 and 7 were similar; they showed a main component with a 
mass of 8030.4 Da and four minor components with masses of 8046.4, 8069.5, 8094.3 and 
7973.5 Da (Fig. 3). The main component corresponds to αį-BgTx-1, that of 8046.4 Da to the 
toxin with oxidized methionine, and those with higher molecular masses may correspond to Na+ 
and/or K+ adducts of the toxin and its oxidized products. The signal at 7973.5 Da may result 
from partial cleavage of C-terminal glycine. The spectra of the products from fraction 3 and 4 
were also similar and showed a main component with a mass of 8143.5 Da and three minor 
components with masses of 8159.2, 8172.7 and 8197.4 Da (Fig. 3). The main component 
corresponds to αį-BgTx-2, that of 8159.2 Da to a methionine oxidized toxin and those with 
higher molecular masses to Na+ and/or K+ adducts. 
 
N-terminal sequence analysis of intact αį-BgTx-1 was successful up to residue 32 (Fig. 
2). To determine the complete sequence, the carboxymethylated preparation of αį-BgTx-1 was 
digested using Asp-N and Glu-C specific proteases, and the resulting fragments were isolated by 
RP-HPLC for subsequent Edman degradation. Overlapping sequences accounting for 72 of the 
73 residues in the αį-BgTx-1 polypeptide were obtained (Fig. 2). The identity of the missing 
residue (position 52) was established by comparing the theoretical mass based on the results of 
Edman degradation and the polypeptide total mass determined by ESI-MS (above); it revealed a 
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Pro-residue in position 52 (Fig. 2). The result from the amino acid sequence analysis of the αį-
BgTx-1 preparation agrees completely with the results of the DNA sequence analysis. Sequence 
comparison between αį-BgTx-1 and α-BgTx (A31) reveals only ten substitutions (I1L, V2L, 
H4Y, T5K, T8P, S12N, V14E, R25T, F32W, V40I) and one deletion (Ala7), respectively. In 
total, the primary structure differences between α-BgTx A31 and αį-BgTx-1 comprise four 
charge-modifying mutations (basic in α-BgTx → hydrophobic in αį-BgTx H4Y; polar → basic 
T5K; hydrophobic → acidic V14E; basic → polar R25T) resulting in one net (cation → anion) 
charge reversal (Fig. 2). 
 
The amino acid sequence of αį-BgTx-2 was confirmed by peptide mass fingerprinting of 
reduced and carbamidomethylated toxins from fractions 3 and 4 after digestion with trypsin. The 
amino acid sequence of the tryptic peptides analyzed by MALDI mass spectrometry (Table 1) 
confirmed the identity of the toxins in the two fractions. With exception of short peptides in the 
middle of the toxin sequence and at the C-terminal, which are hardly detected by MALDI-MS, 
the deduced amino acid sequence of αį-BgTx-2 was almost completely covered by that of the 
tryptic peptides, suggesting that the isolated toxins represent αį-BgTx-1 and αį-BgTx-2. 
 
Toxicity 
 
The LD50 determined by i.p. injection for two different batches of αį-BgTx-1 isolated as 
described in [26] was in the range from 0.17 to 0.28 μg/g. The LD50 of α-BgTx (A31) isolated 
from B. candidus venom was estimated to be 0.13 μg/g. The symptoms produced in mice by αį-
BgTx-1, such as flaccid paralysis and respiratory distress, were similar to those evoked by 
injection of α-BgTx. αį-BgTx-1 caused death in a dose-dependent manner as is typical for α-
BgTx [49]. Death occurred mostly within 2 to 4 h. 
 
Neuromuscular blocking activity of αį-BgTx-1 
 
In the chick biventer cervicis nerve-muscle preparation, both αį-BgTx-1 and α-BgTx 
(A31) produced complete neuromuscular block at all concentrations tested: 12.5 nM – 1.25 μM 
 
15 
and 3.76 nM – 125 nM, respectively. The time to complete neuromuscular block was similar for 
αį-BgTx-1 and α-BgTx at concentrations of 37.6 and 125 nM, but was shorter for α-BgTx at 
12.5 nM (Table 2). Considering the postsynaptic mode of action at the motor endplate, the 
response to acetylcholine was completely abolished when the neuromuscular transmission was 
blocked by either toxin at all concentrations. However, in marked contrast to the block induced 
by α-BgTx, acetylcholine response was completely reversible by washing in the case of αį-
BgTx-1 (Table 2). 
 
Binding of αį-BgTx-1 to the α1ȕ1įİ and α1ȕ1įȖ mouse muscle nAChRs 
 
αį-BgTx-1 showed about 100 to 300 times higher affinity to one of the two ligand 
binding sites of the adult (α1ȕ1įİ) and embryonic form (α1ȕ1įȖ) of mouse muscle nAChRs than 
α-BgTx (Fig. 4). The calculations using a two sites competition model resulted in IC50 values of 
0.0212 ± 0.0032 and 0.115 ± 0.016 nM for high affinity sites on α1ȕ1įİ and α1ȕ1įȖ receptors, 
respectively. The IC50 values for low affinity sites were almost the same for both receptor types: 
20.3 ± 1.2 and 21.8 ± 3.3 nM for α1ȕ1įİ and α1ȕ1įȖ nAChRs, respectively. A competitive 
binding of αį-BgTx-1 in the absence and presence of α-conotoxin MI, which selectively binds to 
the αį-binding site of the receptor, demonstrated that the binding site selectivity of αį-BgTx-1 is 
directed to the αį-subunit interface of the mouse muscle nAChR (Fig. 4). In the presence of α-
conotoxin MI, competition of αį-BgTx-1 only for the low affinity site was observed. The 
calculated IC50 values were 15.7 ± 1.2 and 2.54 ± 0.32 nM for α1ȕ1įİ and α1ȕ1įȖ receptors, 
respectively. The IC50 for the adult receptor was comparable to that of the low affinity site 
determined in the absence of conotoxin, while the similarity was less pronounced for the 
embryonic receptor. 
 
Binding of αį-BgTxs to human neuronal α7 and Torpedo californica nAChRs 
 
The capability of αį-BgTxs to interact with nAChRs was studied by competitive 
radioligand assay using muscle-type nAChR from the T. californica electric organ, the neuronal 
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hα7 nAChR, heterologously expressed in GH4C1 cells, and [125I]α-BgTx (A31), which bound to 
these receptors with KD values of 0.13 ± 0.04 nM and 0.27 ± 0.03 nM, respectively. 
 
On the T. californica nAChR, the IC50 for α-BgTx was 1.23 ± 0.06 nM, while it was 11.4 
 
± 1.8 nM for αį-BgTx-1 and 77 ± 9 nM for αį-BgTx-2 using a one site competition model (Fig. 
 
5A). However, the calculations using a two sites competition model corresponded more precisely 
to the data obtained (Fig. 5A), resulting in IC50 values of 2.0 ± 1.0 and 34 ± 12 nM for αį-BgTx-
1, and of 15 ± 5 and 210 ± 50 nM for αį-BgTx-2. The respective Ki values calculated using the 
 
Cheng and Prusoff equation [50] and Hill coefficients (nH) are presented in Table 3. 
 
IC50 values calculated using a one site competition model for the neuronal hα7 nAChR were 1.18 
 
± 0.05 nM for αį-BgTx-1, 5.2 ± 0.6 nM for αį-BgTx-2 and 0.87 ± 0.11 for α-BgTx (Fig. 5B). 
The respective Ki values and Hill coefficients are provided in Table 3. On the α7 nAChR, αį-
BgTxs have affinities and nH values comparable to those of α-BgTx. However, on the muscle-
type receptor there is a noticeable difference in binding parameters between αį-BgTxs and α-
BgTx. High nH values for ligand binding to nAChRs were observed earlier by our [51] and other 
research groups [52] and might be explained by the limitations of the Hill equation, for example, 
because of the assumption that ligand molecules bind to a receptor simultaneously. 
 
To obtain parameters of direct interaction of αį-BgTx-1 with these two targets, its 
radioiodinated derivative with 500 Ci/mmol was used. Saturating T. californica electric organ 
 
membranes (Fig. 6A) and hα7 receptor of GH4C1 cells (Fig. 6B) with [125I]αį-BgTx-1 resulted 
in the following binding parameters: for α1ȕ1įȖ nAChR - Kd = 0.34 ± 0.03 nM and Bmax = 0.66 
 
± 0.02 nM; for the hα7 receptor - and Kd = 0.52 ± 0.05 nM and Bmax = 1.12 ± 0.06 nM. 
 
The dissociation constants are very close to the corresponding Ki values (see Table 3). It 
should be noted that in a direct radioligand assay using a radioligand ([125I]αį-BgTx-1) with a 
specific radioactivity of 500 Ci/mmol, only a high-affinity binding site on the α1ȕ1įȖ nAChR 
can be detected. Kinetics of the αį-BgTx-1 dissociation from the complex with nAChRs 
 
17 
compared to that of α-BgTx (Fig. 6) indicate that αį-BgTx-1 dissociated much faster than α-
BgTx from the complex with Torpedo nAChR (Fig. 6C), while the release rate from the hα7 
nAChR complex was similar for both toxins (Fig. 6D). The kinetics of the αį-BgTx-1 
dissociation from Torpedo nAChR is better described by a two sites model with koff of 0.10 ± 
0.04 and 0.009 ± 0.001 min-1. For α-BgTx, this value was equal to 0.0017 ± 0.0006 min-1. The 
koff values for hα7 nAChR were 0.0031 ± 0.0003 and 0.0022 ± 0.0006 min-1 for α-BgTx and αį-
BgTx-1, respectively. 
 
Electrophysiological assays 
 
As in the binding experiments on α7 nAChR, αį-BgTx-1 produced effects similar to those 
of α-BgTx (Table 3), its activity was not tested on this receptor subtype in electrophysiological 
 
experiments. Instead, mouse muscle and human neuronal γȕβ nAChRs that had been 
heterologously expressed in Xenopus oocytes were assayed. It was found that a 10 min treatment 
of oocytes with αį-BgTx-1 resulted in a decrease of the ACh-induced current (Fig. 7 A and B). 
Peak response suppression was dependent on the αį-BgTx-1 concentration (Fig 7 A and B). The 
 
IC50  values were 30 ± 9.8 nM (n = 5) for muscle type and 2.9 ± 0.48 (n = 4) M for neuronal 
 γȕβ receptors. At a concentration of 270 M α-BgTx only insignificantly (less than 30%) 
 
inhibited γȕβ nAChR. 
 
To test the reversibility of αį-BgTx-1 action, oocytes expressing mouse muscle nAChRs 
 
and neuronal γȕβ nAChRs were incubated with 15.2 µM αį-BgTx-1 for 10 min. The toxin was 
then washed out at a flow rate of 0.4 ml/min and the receptor response to 30 mM ACh was 
determined every 5 min (Fig. 7 C and D). 
 
The γȕβ nAChR recovered very fast, and full recovery was observed after 10 min 
washing. The recovery of the muscle type receptor was slower and reached only about 50% after 
 
30 min washing. These results demonstrate that in contrast to α-BgTx, the action of αį-BgTx-1 
is easily reversible. 
18 
Molecular modeling of αį-BgTx-1 and docking simulations 
 
Comparison of the models of free α-BgTx and αį-BgTx-1 shows a slight difference in the 
spatial structure of the first loop where αį-BgTx-1 exhibits a sharper ȕ-turn due to its deletion of 
Ala7 and the P8T substitution (Fig. 8). Docking simulations of α-BgTx and αį-BgTx-1 to 
AChBP, and to the interface of the α and Ȗ subunits at the extracellular domain of the Torpedo 
nAChR, resulted in complexes that were very similar to the published α-CTX-AChBP crystal 
structure [43]. The first loop of the toxin contacted the C-loop of the main (positive) side of the 
binding pocket, and α-BgTx seemed to create more contacts in this area than αį-BgTx-1. 
 
According to the αį-BgTx-1 homology model and its template α-BgTx in their 
complexes with the ligand-binding domain of the α1 subunit (see Fig. 8), as shown in the X-ray 
structure of α-BgTx bound to the extracellular domain of the α subunit [41], the only structural 
difference between the two toxins that may result in different affinities, is the shortening of loop 
I leading to a smaller number of contacts with the carbohydrate chain. The receptor C-loop is too 
far to form direct contacts with this part of the toxin loop I. The F32W substitution in loop II 
may push the Arg36 side chain closer to the receptor's loop C residues. However, the rigid 
homology modeling performed does not allow us to speculate on possible effects of this 
substitution on the toxin's affinity. 
 
Discussion 
 
Following a general purification scheme with three chromatographic steps, new toxins 
called αį-bungarotoxins were isolated from B. candidus venom. Interestingly, two isoforms 
differing in ion-exchange chromatography retention times were observed for both αį-BgTx-1 
and αį-BgTx-2 (Fig. 1). These isoforms have identical mass spectra and amino acid sequences as 
confirmed by peptide mass fingerprinting. This finding may be explained by the presence of 
interconvertible conformers of toxin molecules. A similar behaviour was observed for α-BgTx 
under HPLC conditions [53]. Mass spectrometry analysis of the isolated toxins revealed some 
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additional masses which were assigned to methionine oxidation and ion adducts. Methionine 
oxidation is a very common modification of animal toxins. For example, a toxin with completely 
oxidized methionine residue was purified from scorpion venom [54], and a similarly modified 
phospholipase A2 was isolated from snake venom [55]. Toxin derivatives with oxidized 
methionine are not always easily separated from original toxins. For example, a 37-residue 
scorpion toxin (kaliotoxin) was not resolved from its oxidized derivative under isocratic HPLC 
conditions [56]. Thus, it is possible that αį-BgTx derivatives with oxidized methionine are not 
separated from unmodified toxins. In the mass spectrum of αį-BgTx-1, a signal corresponding to 
the mass of 7973.5 Da was observed and assigned to a toxin derivative without C-terminal 
glycine residue. The removal of a small uncharged glycine residue may not strongly change the 
chromatographic properties of αį-BgTx-1 resulting in co-elution of such a shortened analogue 
with the unmodified toxin. In some animal toxins C-terminal glycine undergoes oxidative 
cleavage with amidation of the C-terminus. However, in snake venoms only one C-amidated 
toxin (α-elapitoxin-Dpp2d) has been found so far [57]. Overall, C-terminal glycine is not 
common in snake neurotoxins. Among three-finger neurotoxins isolated from snake venoms we 
were able to find only one more toxin with a C-terminal glycine in addition to αį-BgTx-1 and α-
BgTx, α-elapitoxin Dv2a from the venom of the Western Green Mamba (Dendroaspis viridis). 
Interestingly, a variant of this toxin that lacks a C-terminal glycine was isolated from the mamba 
venom along with the original toxin [58]. 
 
The three novel nicotinic receptor antagonists (αį-BgTxs) from the venom of B. candidus 
constitute a novel subgroup of snake long-chain α-neurotoxins with high similarity to the classic 
receptor probe α-BgTx. In spite of the paucity of structural differences between α-BgTx and αį-
BgTx-1, there are dramatic functional differences between them: binding-site selectivity at the 
mouse muscle and T. californica nAChRs, reversibility in the chick biventer cervicis nerve- 
 
muscle preparation, and some differences in their action on mouse muscle and neuronal γȕβ 
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nAChRs. These findings are entirely new for the group of snake long-chain neurotoxins 
rendering αį-BgTxs promising natural tools for probing nAChRs of various species and 
subtypes. 
 
Compared to the LD50 calculated here for α-BgTx and previously reported values (e.g., 
0.15 μg/g [15] and 0.23 [0.17-0.30] μg/g [26], both by i.p. injection), the lethal toxicity of the 
two αį-BgTx-1 preparations for mice is only marginally lower. Their high toxicity, along with 
the fact that αį-BgTx-1 and αį-BgTx-2 are the major polypeptide toxins of Thai B. candidus 
venom (Fig. 1), suggests that αį-BgTxs assume an important biological role for subduing the 
prey of these snakes. α-Neurotoxins utilize a common binding core consisting of positively 
charged and aromatic residues to establish contacts with key invariant residues on the nAChR. 
Moreover, each toxin uses other residues to recognize and interact with subtype-specific receptor 
residues. Data from mutagenesis studies, pairwise mutagenesis and structural data on α-BgTx 
binding to α1- or α7-fragments [59-61] or to combinatorial peptides [62-64], X-ray structure data 
of the α-CTX-AChBP complex [43] and of the crystal structure of α-BgTx bound to the 
extracellular domains of the mouse nAChR α1 subunit [41], to neuronal α9 [65] or to the 
chimera of AChBP and to the α7 domain [66], provide a conceptual framework for inferences 
regarding some of the differences between αį-BgTx-1 and α-BgTx. For example, based on the 
localization of some toxin sites remote from those of the receptor, it can be assumed from the 
models that the four charge-modifying mutations - three of them (H4Y, T5K, V14E) in loop I of 
the toxin and the fourth (R25T) in loop II - as well as the hydrophobic↔hydrophobic 
substitutions I1δ and Vβδ or the polar↔polar substitution S1βN have no effect on the activity. 
 
The functional significance of the multiple cationic and aromatic residues of α-
neurotoxins, in particular of lysines, arginines, tryptophans, and phenylalanines of loop II, has 
been independently verified by mutagenesis studies on the short-chain neurotoxin erabutoxin a 
from the venom of the sea snake Laticauda semifasciata [67], on the binding-site selective 
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mutant of the short-chain neurotoxin NmmI from the spitting cobra Naja mossambica [39], and 
by structural studies of α-BgTx complexes with nAChR fragments [61]. The most critical residue 
of the short-chain neurotoxins is an invariant Arg33 located at the very tip of loop II [67] which 
engages in electrostatic interactions with multiple electronegative residues of the receptor [39]. 
In α-BgTx, the invariant residue Arg36 together with Lys38 forms a cationic cluster at the tip of 
loop II of both αį-BgTx-1 and α-BgTx (Figs. 2, 8). In this important region of αį-BgTx-1 and α-
BgTx, there are only three substitutions, namely R25T, V40I, which are relatively close to the tip 
of loop II, and F32W, which is also located at the tip (Figs. 2, 8). The R25T substitution is 
constant in all three isoforms of αį-BgTxs and reduces the cationic charge of these toxins in a 
region of α-neurotoxins that is known to be critical for receptor binding [39, 59-60]. Val40 of α-
BgTx is known to interact with residues Y187 and E188 of the neuronal α7 nAChR [61] and 
with residue S191 in the extracellular domain of the mouse α1 nAChR [41]. However, it seems 
doubtful that the mere introduction of an additional methyl group by the V40I substitution 
(which is present only in αį-BgTx-1; Fig. 2) would have significant effects on these interactions. 
αį-BgTx-2, being less active than αį-BgTx-1, contains a Val-residue at this position. The third 
substitution in loop II (F32W) - although retaining the aromatic character at this position - 
introduces a more bulky residue to an exposed site at the tip of loop II, changing the three-
dimensional configuration at the tip of the loop due to the differing functional groups of these 
residues (Fig. 8) which in turn may result in an alteration of toxin selectivity. 
 
According to the structure of the complex consisting of the extracellular domain of the 
nAChR subunit α1 with α-BgTx [41], the tip of α-BgTx loop II possesses a helix-like 
conformation resulting in the same orientation of the Arg36 and Phe32 side-chains which are 
directed to the main side of the binding pocket: Phe32 serves as part of a "hydrophobic box" and 
Arg36 protrudes into the box, resulting in multiple π-cation interactions with the receptor’s 
aromatic residues. 
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Another remarkable structural difference shared by all three αį-BgTxs, namely the 
deletion of Ala7 in the α-BgTx sequence (Fig. 2), is likely to be involved in the divergent 
functional properties of αį-BgTx-1. Located at the tip of loop I, this residue of α-BgTx, as well 
as the Thr6, Thr8 and Ser9 residues, make numerous polar contacts with the sugar moiety of the 
α1 subunit [41]. In addition, the deletion of the Ala-residue leads to a reduction of the number of 
amino acids that are exposed in the direction of the receptor. According to published structures 
and docking data, this may affect the function of neighbouring residues and explain their 
different affinities to nAChRs [68]. Among long-chain neurotoxins, Thr8 is highly conserved 
and was found to interact with residues W187, K185, and L199 of the α1 subunit of the T. 
californica nAChR [60]. The substitution of this functionally significant residue by hydrophobic 
proline (T8P) in all three αį-BgTx isotoxins is remarkable and may play an important role in the 
divergent binding properties of αį-BgTx-1. 
 
Both short- and long-chain α-neurotoxins in general and α-BgTx in particular [69] do not 
distinguish between binding sites in the mouse muscle nAChR. However, mutation studies on 
the recombinant short neurotoxin NmmI from N. mossambica venom showed that removal of a 
positive charge at conserved residues in loop II of the toxin (K27E or R33E) led to an overall 
decrease in receptor affinity, while introducing other residues resulted in mutants that recognized 
with high affinity the αį site [39]. Thus, the R25T positive charge removal in loop II of αį-
BgTxs may be of similar significance for distinguishing the two binding sites in the muscle-type 
nAChR. As the nAChR į-subunit has a larger F-loop (residues 163-177) than the Ȗ-subunit 
(residues 165-171), this may slightly "push" αį-BgTx towards the complementary side of the 
binding pocket, rendering its position more like that of α-BgTx. This may increase the number of 
interactions between its first loop, the nAChR C-loop and the carbohydrate chain, which may 
contribute to the increased affinity of the toxin to the αį binding site. Previously, it has been 
 
found that the inhibition of the muscle (1ȕ1Ȗį) nAChR by the non-conventional toxin candoxin 
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from B. candidus venom was characterized by different affinities for the two distinct binding 
sites on the receptor [70]. Some explanations have been suggested, however, further studies are 
necessary to understand these differences in affinity. 
 
The results of the present study show that αį-BgTx-2 is about one order of magnitude 
less active than αį-BgTx-1 in receptor competition with α-BgTx. Differences in the amino acid 
sequence of the two toxins include replacement of S9, A31, I40 and G74 in αį-BgTx-1 by I9, 
I31, V40 and N74 in αį-BgTx-2, respectively. The changes to more bulky residues at positions 9 
and 31 in αį-BgTx-2 may disturb its interactions within the receptor binding site. A decrease in 
the net positive charge by replacing G74 with Asp may further affect toxin-receptor interactions. 
 
In contrast to α-BgTx, blocking of the nicotinic receptor by αį-BgTx-1 in the isolated 
chick biventer cervicis nerve-muscle preparation was completely reversible by washing. The 
same effect was also observed in electrophysiological experiments using mouse muscle and 
 
neuronal γȕβ nAChRs as well as in radioligand experiments on Torpedo nAChR. Similar 
effects were reported for candoxin [70] and explained by the absence of an Asp residue at 
position 31 (homologous to position 30 in αį-BgTxs; Fig. 2). However, all αį-BgTx variants 
contain an Asp-residue at this position. Therefore, the reversibility of αį-BgTx actions warrants 
further investigation. 
 
The discovery of αį-BgTxs underscores the relevance and potential of snake venoms as a 
source of novel nicotinic receptor probes ([22], reviewed in [9-10]), especially in view of the fact 
that the venoms of the majority of snake species are still unexplored. However, even in the well-
studied venoms of species like B. multicinctus or N. kaouthia, the high molecular diversity of 
snake neurotoxins offers great opportunities to isolate novel polypeptides (e.g., [57,71-72]) for 
dissecting the structure-function relationships of acetylcholine receptors and to label particular 
receptor subtypes. In analogy to chemical modifications of known toxins or of recombinant 
chimeric toxins, systematic studies of natural toxin subfamilies comprising ligands of nicotinic 
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receptors that differ only in a few substitutions may lead to additional insights and provide 
valuable tools to distinguish binding sites and receptor subtypes of different species. 
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Table 1. Comparison of theoretical digestion fragments of toxin αį-BgTx-2 deduced from the 
 
DNA sequence with those found in tryptic digest of isolated toxin. 
 
Molecular masses (Da)   
    
Position in amino acid Determined for  
Sequence 
  
Calculated sequence of αį-BgTx-2 toxin of toxin of 
 
fraction 3 fraction 4    
     
2275.2 2275.2 2275.1 TPIPINAETCPPGENLCYTK 6-26 
     
1616.8 1616.8 1617.0 KPYEEVTCCSTDK 52-64 
     
1400.7 1400.7 1400.6 MWCDIWCSSR 27-36 
     
1391.7 1391.8 1391.7 VVELGCAATCPS K 39-51 
     
752.4 752.4 752.4 CNPHPK 65-70 
     
696.4 696.4 696.4 LLCYK 1-5 
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Table  2.  Comparison  of  neuromuscular  blocking  actions  of  αį-BgTx-1  and  α-BgTx  from 
 
Bungarus candidus venom on the chick biventer cervicis nerve-muscle preparation. 
 
Toxin Concentration Time (min) to Acetylcholine Reversibility 
 (nM) neuromuscular block response after  
  (mean±S.D. (number of neuromuscular  
  experiments)) block  
      
 1250 11 ± 1 (3) - + 
      
αį-BgTx-1 125 38 ± 8 (4) - +      
37.6 86 ± 8 (4) - + 
 
     
 12.5 > 300 (1) - + 
      
 125 32 ± 5 (3) - - 
      
α-BgTx 37.6 75 ± 3 (3) - -      
12.5 128 ± 17 (3) - - 
 
     
 3.76 > 300 (2) - - 
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TABLE 3. Ki and nH values for binding of toxins to the T. californica and hα7 nAChRs. 
 
Receptor     Ki, nM (nH)     
          
 α-BgTx  αį-BgTx-1   αį-BgTx-2  
        
   one site  two sites one site two sites 
           
Torpedo 0.270 ± 0.013 2.5 ± 0.4  0.44 ± 0.22 29 ± 3 5.7 ± 1.9 
 (3.4 ± 0.5) (0.65 ± 0.07)  7.5 ± 2.6 (0.80 ± 0.09) 80 ± 19 
            
hα7 0.240 ± 0.031 0.330 ± 0.014   - 1.40 ± 0.16  - 
 (1.13 ± 0.13) (1.7 ± 0.1)    (1.20 ± 0.14)   
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Figure 1. Liquid chromatography of crude Bungarus candidus venom from Thailand. 
 
(A) Gel-filtration of crude venom on a Superdex 75 column (1 × 30 cm) eluted with 0.1 M 
ammonium acetate (pH 6.2) at a flow rate of 0.5 ml/min. Twelve major fractions were collected. 
 
(B) Cation-exchange chromatography of fraction 8 on a HEMA BIO 1000 CM column (8 × 250 
mm, Tessek, Czech Republic) using a gradient of ammonium acetate concentration from 5 mM 
to 45 mM in 100 min at a flow rate of 1.0 ml/min. Dashed line indicates the concentration 
gradient generated at the input of the column. 
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Figure 2. Amino acid sequence determination of αį-BgTxs. 
 
Top: Sequence alignment of B. candidus neurotoxins deduced from genomic DNA, their 
theoretical masses (corrected for the presence of five disulfide bonds) and isoelectric points. αį-
BgTx residues that differ from α-BgTx A31 are shaded; sequence differences that may be 
responsible for the different binding properties of αį-BgTx-1 are shaded black; residues 
interrupted by introns are underlined. Bottom: Amino acid sequence of αį-BgTx-1 obtained by 
Edman degradation. N-terminal sequencing of the native toxin was performed twice; further 
sequence analysis was performed using carboxymethylated αį-BgTx-1 after digestion by Asp-N 
(indicated by D) and Glu-C (indicated by E) specific proteases and isolation of fragments by RP-
HPLC (numbers refer to specific fractions). 
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Figure 3. ESI-MS analyses of B. candidus αį-BgTxs. 
 
A - αį-BgTx-1; B - αį-BgTx-2. 
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Figure 4. Competition binding curves for αį-BgTx-1 with [125I]α-BgTx initial binding rate 
to mouse muscle nAChRs transiently expressed in HEK293 cells, in the absence and 
presence of 30 nM α-conotoxin MI. 
 
(A) Binding of αį-BgTx-1 to embryonic form (α1ȕ1įȖ) nAChR. (B) Binding of αį-BgTx-1 to 
adult form (α1ȕ1įİ) nAChR. Binding curves in the presence α-conotoxin MI display a right-
ward shift only in the high-affinity site, indicating that the α−į site is the high affinity site for αį-
BgTx-1. 
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Figure 5. Competition of αį-BgTxs and α-BgTx with [125I]α-BgTx. 
 
(A) Competition of αį-BgTxs and α-BgTx with [125I]α-BgTx for binding to Torpedo californica 
muscle-type nAChRs. (B) Competition of αį-BgTxs and α-BgTx with [125I]α-BgTx for binding 
neuronal hα7 nAChRs. 1 - αį-BgTx-1, 2 - α-BgTx, 3 - αį-BgTx-2. 
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Figure 6. Direct radioligand assay of [125I]αį-BgTx-1 on T. californica muscle-type and 
 
neuronal hα7 nAChRs. 
 
Saturation binding curves for [125I]αį-BgTx-1 (from 0.02 to 1.25 nM) interaction with the (A) T. 
californica α1ȕ1įȖ nAChR and (B) neuronal hα7 nAChR transfected in GH4C1 cells. The 
respective Kd and Bmax values are shown calculated from a single experiment (duplicated for 
each point). Dissociation of BgTxs from complexes with Torpedo nAChR (C) and hα7 nAChR 
 
(D). 
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Figure 7. Electrophysiological assays on nAChRs heterologously expressed in Xenopus 
 
oocytes. Dose-response curve of αį-BgTx-1 inhibitory action on the ACh-evoked (30 µM ACh) 
 
ionic current mediated by mouse muscle (A) or human neuronal γȕ2 (B) nAChR. Oocytes were 
incubated with αį-BgTx-1 for 10 min, followed by the application of γ0 με acetylcholine. All 
currents were normalized for the current evoked by γ0 με ACh. The IC50 values were 30 ± 9.8 
 
nM (n = 5) and 2.9 ± 0.48 M (n = 4) for muscle and γȕβ nAChR, respectively. Time course of 
the recovery of nAChR response to acetylcholine after the block produced by αį-BgTx-1 in 
mouse muscle type (C) or neuronal γȕβ (D) nAChRs. Oocytes were incubated with 15.2 µM 
 
αį-BgTx-1 for 10 min and then washed out at a flow rate of 0.4 ml/min. The response to 30 M 
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acetylcholine before incubation with αį-BgTx-1 was taken as 100% and was then registered 
 
every 5 min (n=3). εembrane potential was clamped at −60 mV. 
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Figure 8. Comparison of the three-dimensional homology model of αį-BgTx-1 (red) aligned 
with the α-BgTx (blue) template taken from the crystal structure of its complex with the 
extracellular domain of the nAChR subunit α1 [41]. 
 
Shown are (a) the free toxins aligned, (b) αį-BgTx-1 aligned to α-BgTx as appearing in the X-
ray structure in complex with the ligand-binding domain of nAChR subunit α1, (c) the loop 1 of 
both toxins in complex with the receptor enlarged, and (d) loop 2 of both toxins in that complex. 
Some of the important amino acid residues of αį-BgTx-1 (black numbers) and the receptor 
(purple numbers) are highlighted. Note the slight difference in the spatial structure of the first 
loop with αį-BgTx-1 exhibiting a sharper ȕ-turn due to the deletion of A7 and the P8T 
substitution and the orientation of W31 and R35 (enumeration according to αį-BgTx-1) in the 
hydrophobic box of the receptor residues. 
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Supplementary Figure 1: Final purification of αį-BgTx-1 (C and D) and αį-BgTx-2 (A and 
B) by reversed phase HPLC. 
 
Fractions obtained after ion-exchange chromatography (3, 4, 6 and 7 in Fig. 1B) were separated 
on a Phenomenex C18 column (10 250 mm) applying a gradient of 20% to 40 % (v/v, in 60 min) 
acetonitrile containing 0.1% (v/v) trifluoroacetic acid, at a flow rate of 2.0 ml/min. The profiles 
A, B, C and D show the separation of fractions 3, 4, 6 and 7, respectively. The horizontal bars 
indicate the fractions collected for further studies. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 2. Schematic drawing showing the genetic organization of the α-BgTx (A31 and V31) genes 
according to Chang et al. (1999) and approximate positions (dots) of the oligonucleotide primers P2 and P5. 
 Amino 
                           
 
acid 
                           
BgTx substitutions   *     20 * 40 * 60 *  74 Mass (Da) pI 
α-1 A31  C   T                  IV  T ATSPI S A V TCPPGENLCY  KMWCD A  CSSRGKV V ELGCAATCPSKKPYEEVTCCSTDKCNPHPKQRP G 7984.18 8.38 
α-2 V31 IV C  T T ATSPI S A V TCPPGENLCY  KMWCD V F CSSRGKV V ELGCAATCPSKKPYEEVTCCSTDKCNPHPKQRP G 8012.30 8.38 
αδ-1 I39 LL C   T                       
  -PSPI N A E TCPPGENLCY T KMWCD A  CSSRGKV I ELGCAATCPSKKPYEEVTCCSTDKCNPHPKQRP G 8031.23 8.09 
αδ-2 I8/I30/D73 LL C   T-P I PI N A E TCPPGENLCY T KMWCD IW CSSRGKV V ELGCAATCPSKKPYEEVTCCSTDKCNPHPKQRP D 8157.43 7.63 
αδ-3 D73 LL C   T-PSPI N A E TCPPGENLCY T KMWCD A  CSSRGKV V ELGCAATCPSKKPYEEVTCCSTDKCNPHPKQRP D 8075.24 7.63 
 <─────────────  Exon β ───────────────><─────────────────  Exon γ ────────────────────>  
  ├──── δoop 1 ────┤  ├────────  Loop 2 ────────┤ ├──────  δoop γ  ──────┤     
 
 
Supplementary Figure 3. Amino acid sequences, theoretical masses corrected for five disulfide bonds, and theoretical pIs of unique mature α-BgTx and αį-BgTx 
polypeptides deduced from genomic DNAs. Variable residues shaded by the chemical property mode of Genedoc 2.6 using the programme's default settings. Residues interrupted 
by intron 2 appear in bold print. α-BgTx-1 and α-BgTx-2 (A31 and V31 isoforms, respectively) are from Chang et al. (1999). The numbers of amino acid replacements in αį-BgTxs 
are given without taking into account the deletion in position 7. 
 
 
 
 
 
 
 
 
1 2 3 4 5 6 7 
 
8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 
α-BgTx-1 GATATACCATCGTATGCCACACAACAGCTACTTCGCCTATTAGCGCTGTGACTTGTCCACCTGGGGAGAACCTATGCTATAGAAAGATGTGGTGTGATGCATTCTGTTCCAGCAGAGGAAAGGTAGTCGAATTGGGGTGTGCTGCTACT 
α-BgTx-2 GATATACCATCGTATGCCACACAACAGCTACTTCGCCTATTAGCGCTGTGACTTGTCCACCTGGGGAGAACCTATGCTATAGAAAGATGTGGTGTGATGTATTCTGTTCCAGCAGAGGAAAGGTAGTCGAATTGGGGTGTGCTGCTACT 
αδ-BgTx-1 GATATACCTTGTTATGCTACAAAACA   ---            CCTTCACCTATTAACGCTGAGACTTGTCCACCTGGGGAGAACCTATGCTATACGAAGATGTGGTGTGATGCATGGTGTTCCAGCAGAGGAAAGGTAATCGAATTGGGATGTGCTGCTACT       
αδ-BgTx-2 GATATACTTTGTTATGCTACAAAACA   ---             CCTATACCTATTAACGCTGAGACTTGTCCACCTGGGGAGAACCTATGCTATACAAAGATGTGGTGTGATATATGGTGTTCCAGCAGAGGAAAGGTAGTCGAATTGGGATGTGCTGCTACT    
αδ-BgTx-3 GATATACCTTGTTATGCTACAAAACA   ---            CCTTCACCTATTAACGCTGAGACTTGTCCACCTGGGGAGAACCTATGCTATACGAAGATGTGGTGTGATGCATGGTGCTCCAGCAGAGGAAAGGTAGTCGAATTGGGATGTGCTGCTACT    
 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 *  Accession no.  
α-BgTx-1 TGCCCTTCAAAGAAGCCCTATGAGGAAGTTACCTGTTGCTCAACAGACAAGTGCAACCCACATCCGAAACAGAGACCTGGTTGA Y17693  
α-BgTx-2 TGCCCTTCAAAGAAGCCCTATGAGGAAGTTACCTGTTGCTCAACAGACAAGTGCAACCCACATCCGAAACAGAGACCTGGTTGA Y17694 
 
αδ-BgTx-1 TGCCCTTCAAAGAAGCCCTATGAGGAAGTTACCTGTTGCTCAACAGACAAGTGCAACCCACATCCGAAACAAAGACCTGGTTGA       AM231681  
αδ-BgTx-2 TGCCCTTCAAAGAAGCCCTATGAGGAAGTTACCTGTTGCTCAACAGACAAGTGCAACCCACATCCGAAACAGAGACCTGATTGA     AM231682  
αδ-BgTx-3 TGCCCTTCAAAGAAGCCCTATGAGGAAGTTACCTGTTGCTCAACAGACAAGTGCAACCCACATCCGAAACAGAGACCTGATTGA 
    
AM231680 
 
 
 
Supplementary Figure 4. Joined nucleotide sequences of exons 2 and 3 encoding unique α-BgTx and αį-BgTx precursors. Toxin numbering is that of Fig. S3 Exon boundary 
indicated by triangle; 3'-non-coding nucleotides of exon 3 deleted. Numbers above sequences indicate the amino acid residues of mature α-BgTx. Unnumbered 5'-terminal 
nucleotides of exon 2 encode part of the signal peptide. Codons with substitutions relative to the α-BgTx-1 sequence are coloured; red and green highlight non-synonymous and 
synonymous substitutions, respectively; yellow, nucleotides that are invariant in these codons. α-BgTx-1 and α-BgTx-2 (A31 and V31 isoforms, respectively) are from Chang et al. 
(1999). 
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  Primer Direction Length Sequence (5' to 3') Tm Reference 
 Name  (nt)  (°C)  
      
       
 P2 H 24 GGATGGTCCTTGATGGATGAGAGC 67.11 Chang et al. 
      (1999) 
       
 P5 L 25 GGGGAATGAGTATATACTTGTGTTT 59.66 Kuch et al. (2003) 
       
 
Supplementary Table 1. Oligonucleotide primers used for PCR amplifications of αį-BgTx encoding gene 
sequences. 
 
The primer P2 of Chang et al. (1999) is based on the 3'-untranslated region of cobrotoxin and cardiotoxin genes 
(Fig. S1; Chang et al., 1997), and the primer P5 is designed to match a sequence upstream from exon 2 of the α-
BgTx (A31) gene (Fig. S1; Kuch et al., 2003). 
